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ABSTRACT  The mammalian endoplasmic reticulum (ER) is an organelle that maintains a com-
plex, compartmentalized organization of interconnected cisternae and tubules while sup-
porting a continuous flow of newly synthesized proteins and lipids to the Golgi apparatus. 
Using a phenotypic screen, we identify a small molecule, dispergo, that induces reversible 
loss of the ER cisternae and extensive ER tubulation, including formation of ER patches com-
prising densely packed tubules. Dispergo also prevents export from the ER to the Golgi ap-
paratus, and this traffic block results in breakdown of the Golgi apparatus, primarily due to 
maintenance of the constitutive retrograde transport of its components to the ER. The effects 
of dispergo are reversible, since its removal allows recovery of the ER cisternae at the ex-
pense of the densely packed tubular ER patches. This recovery occurs together with reactiva-
tion of ER-to-Golgi traffic and regeneration of a functional Golgi with correct morphology. 
Because dispergo is the first small molecule that reversibly tubulates the ER and inhibits its 
export function, it will be useful in studying these complex processes.
INTRODUCTION
The mammalian endoplasmic reticulum (ER) is a large membrane 
network of interconnected cisternae or sheets and tubules located 
throughout the cytosol (Baumann and Walz, 2001; Shibata et al., 
2006; Lu et al., 2009, 2011). Protein and lipid synthesis and certain 
posttranslational modifications occur within its membrane-bound 
compartments. During mitosis, the ER architecture undergoes a 
major rearrangement to extended cisternae, with a very small frac-
tion remaining organized as tubules (Lu et al., 2009, 2011). During 
interphase newly made secretory proteins leave the ER in COPII-
based transport carriers, which bud from specialized ER exit sites 
(ERES) scattered throughout the ER. These carriers coalesce to 
form the vesicular-tubular network of the so-called ER Golgi inter-
mediate  compartment  (ERGIC).  Elements  of  the  intermediate 
compartment that contain newly synthesized proteins are continu-
ously transported along microtubules toward the perinuclear re-
gion, where they deliver their contents to the cis face of the Golgi 
apparatus. Fully processed proteins exit at the opposite end of the 
Golgi, the trans face, to reach the trans-Golgi network (TGN), from 
which they are transported to the plasma membrane and endo-
somes (Emr et al., 2009).
The dynamics of the Golgi apparatus, critical for all its functions, 
can be studied by the use of reagents that trap the Golgi in states 
that are usually sparsely populated or are not present in a normal 
cell. Cell-permeable small molecules with these properties are use-
ful, particularly because they can be specific, fast acting, and re-
versible, allowing detailed study of Golgi disassembly and reas-
sembly. In contrast, no equivalent chemicals are available to study 
the organization and function of the ER. By use of a phenotypic 
screen of inhibitors of exocytic vesicular traffic, we discovered a 
small molecule, which we call dispergo (“disrupt ER and Golgi”), 
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The effect of dispergo on the organization of the ER also occurred in 
cells whose protein synthesis was acutely blocked by cycloheximide 
treatment (unpublished data).
These observations led us to examine in more detail the effects 
of dispergo on the architecture of the ER. Thin-section transmission 
electron  microscopy  of  cells  treated  with  dispergo  indicate  the 
appearance of numerous clusters containing densely packed mem-
brane profiles ∼50 nm in diameter (Figure 3F, solid arrowheads) 
that causes a rapid change in the architecture of the ER, involving 
loss of cisternae and extensive tubulation, including formation of 
densely packed tubules throughout the cytoplasm, rendering ex-
port from the ER nonfunctional. Lack of anterograde transport from 
the ER eventually causes loss of the Golgi apparatus together with 
retention of its contents in the ER. Removal of dispergo leads to 
reestablishment  of  the  ER  architecture:  ER  cisternae  reappear, 
densely packed ER tubules disappear, membrane transport from 
the ER reactivates, and a functional Golgi apparatus reassembles.
RESULTS
Identification of dispergo as an inhibitor of VSVGts–green 
fluorescent protein export from the ER
Using an image-based, high-throughput phenotypic assay that we 
developed  previously  for  inhibitors  of  VSVGts–green  fluorescent 
protein (GFP) exocytic vesicular traffic (Feng et al., 2003) to screen a 
diversity-oriented library of 10,000 small molecules resembling the 
natural product carpanone, we identified a number of compounds 
that block VSVGts-GFP exit from the Golgi or cause Golgi fragmen-
tation (Goess et al., 2006). We chose to use a natural product as the 
core structure for the diversity-oriented synthesis because we hy-
pothesized that such structures would have a higher intrinsic ability 
to bind proteins. This strategy proved to be successful, as shown by 
our recent discovery of secramine, a cell-permeable, galanthamine-
like molecule found to be an inhibitor of vesicular traffic from the 
Golgi by interference with the function of the small GTPase Cdc42 
(Pelish et al., 2006). We describe here a new molecule identified in 
the same screen, which we call dispergo (Figure 1A). It inhibits, with 
IC50 ≈ 6.8 μM, traffic of VSVGts-GFP from the ER to the plasma 
membrane in BSC1 cells upon transfer from 40 to 32°C (Figure 1, B 
and C); it is also active in HeLa and Chinese hamster ovary cells 
(unpublished data). Carpanone (Figure 1A), which inspired the li-
brary from which dispergo was identified, is inactive (Figure 1, B and 
C); in its presence, as in untreated cells, VSVGts-GFP accumulates in 
the ER in cells kept at 40°C and rapidly reaches the Golgi apparatus 
and the plasma membrane soon after transfer to 32°C.
In addition to rapidly inhibiting VSVGts-GFP traffic to the plasma 
membrane, dispergo also prevented VSVGts-GFP from reaching the 
Golgi apparatus marked with GalT-tomato (compare the control in 
Figure 2A with dispergo in Figure 2, B and C). Instead we saw the 
appearance of bright VSVGts-GFP patches in cells maintained at 
40°C or in cells transferred from 40 to 32°C (Figure 2, B and D); 
these VSVGts-GFP patches colocalized with newly formed patches 
of the ER marker TRAPα (Figure 2D).
Reversible changes of the ER architecture induced 
by dispergo
We then followed the effect of dispergo on the distribution of an-
other ER marker, GFP- Sec61β, and found the rapid accumulation of 
bright GFP-Sec61β patches (Figure 3A, top, arrowheads, and Sup-
plemental Movie S2). The appearance of the ER patches coincided 
with extensive ER tubulation and loss of ER cisternae (Figure 3B, 
solid arrowheads). The effect of dispergo on the ER architecture was 
reversible, as demonstrated by the disappearance of the ER patches 
during the washout period along with the abrupt reappearance of 
ER cisternae (Figure 3C); eventually, the cells recovered the charac-
teristic  combination  of  cisternae  and  tubules  in  interphase  cells. 
GFP-Sec61β within the dispergo-induced patches exchanged rap-
idly, presumably though direct connections between the patches 
and the surrounding ER, as shown by the relatively fast recovery of 
fluorescence signal in photobleached patches, with half-times in the 
range of 20–100 s (Figure 3, D and E, and Supplemental Movie S3). 
FIGURE 1:  Dispergo inhibits the traffic of VSVGts-GFP from the ER to 
the plasma membrane. (A) Structures of synthetic dispergo and the 
related natural product carpanone. (B) Inhibitory effect of dispergo on 
the arrival of VSVGts-GFP to the cell surface. BSC1 cells were 
transduced with adenovirus to express VSVGts-GFP overnight at 40°C. 
Cells were subsequently incubated with DMSO (control), dispergo, or 
carpanone at the nonpermissive temperature (40°C) for 1 h, followed 
by incubation at the permissive temperature (32°C) for 3 h. VSVGts at 
the cell surface was detected by incubation by the 8G5 monoclonal 
antibody specific for the ectodomain of VSVG. Scale bar, 60 μm. 
(C) The effect of dispergo on the arrival of VSVGts-GFP to the cell 
surface was quantified by determining for each cell the ratio of the 
surface 8G5 fluorescence signal corrected by background to the total 
VSVGts-GFP fluorescence signal. Data are presented as a semilog plot 
for results obtained from ∼1500 cells imaged in three independent 
experiments. Values for each point are mean ± SD; the IC50 (∼6.8 μM) 
was calculated as the concentration at which 50% of the VSVG signal 
was present at the cell surface.1022  |  L. Lu et al.  Molecular Biology of the Cell
were often associated with additional membrane profiles, ∼100 nm 
wide,  extending  toward  adjacent  regions  within  the  cytosol, 
perhaps communicating with other clusters or with the rest of the 
ER (Figure 3F, enlargement, open arrowheads). We found no mor-
phological evidence to support the presence of a limiting mem-
brane surrounding the tubular clusters.
The patches induced by dispergo contained the ER membrane 
marker  HA-DP1  (Supplemental  Figure  S1A),  the  endogenous  ER 
luminal protein calreticulin (Supplemental Figure S1B), and the ER 
retention signal KDEL fused to GFP (ss-GFP-KDEL; Supplemental 
Figure S1C). The fluorescence intensities associated with calreticulin 
or ss-GFP-KDEL in the ER patches were significantly lower (Supple-
mental Figure S1, B and C, arrowheads), consistent with a lower vol-
ume-to-membrane  ratio  in  tubules  than  in  cisternae.  Similar  ER 
patches tracked with these markers were also observed in other cells, 
such as NRK, HeLa, Ptk2, and mouse MEF cells (unpublished data). 
We  note  that  dispergo  treatment  led  to  efficient  formation 
of ER patches in cells that did not express ER protein markers (Supple-
mental Figure S1, D, E, and F), suggesting that the patches do not 
correspond to the organized smooth ER associated with the stacking 
of smooth ER (Snapp et al., 2003) or to patches of smooth ER induced 
by phenyl-2-decanoyl-amino-3-morpholino-1-propanol-hydrochloride 
(Sprocati et al., 2006), as these ER morphologies only seem to appear 
upon ectopic overexpression of ER membrane proteins.
Generation and maintenance of the ER tubular network require 
the presence of microtubules (Terasaki et al., 1986; Waterman-Storer 
and Salmon, 1998; Lu et al., 2009). We found, however, that the 
extensive ER tubulation induced by dispergo treatment does not 
depend on the microtubule network. We first treated BSC1 cells 
with nocodazole to depolymerize microtubules, leading to loss of 
ER tubules and formation of ER cisternae (Figure 3G, left; Lu et al., 
2009). We then followed this treatment by incubating with nocoda-
zole and dispergo together for 3 h and found that dispergo induced 
formation of ER tubules and ER patches at the expense of ER cister-
nae, despite the continued presence of an inhibitor of microtubule 
dynamics (Figure 3G, right).
Dispergo disrupts recruitment of exocytic cargo to the ERES
Cargo export from the ER to the Golgi apparatus is mediated by 
vesicular carriers that form at ERES and contain Sec31a, a compo-
nent of the COPII coat (Lee et al., 2004). Because dispergo inhib-
its the ER export of VSVGts-GFP (Figure 2B), we asked whether 
dispergo might inhibit ER export by preventing the recruitment of 
Sec31a to ERES. We found no statistical difference (p = 0.40) in 
the density of Sec31a-containing fluorescent spots in the absence 
(0.25 ± 0.05 μm−2; n = 20 cells) or presence of dispergo (0.21 ± 
0.07 μm−2; n = 15 cells; Supplemental Figure S2A). In contrast to 
these results, we found that VSVGts-GFP failed to accumulate at 
ERES in cells treated with dispergo. In control cells not treated 
with dispergo and maintained at the nonpermissive temperature 
of 40°C, VSVGts-GFP displayed the expected homogeneous dis-
tribution throughout the ER and absence of concentration in the 
ERES marked with Sec31a (Figure 4A). A 10-min incubation at the 
permissive temperature of 32°C led to the expected concentra-
tion of VSVGts-GFP on the ERES and its accumulation in the peri-
nuclear region associated with the Golgi apparatus (Figure 4B). In 
contrast, cells treated with dispergo at 40°C accumulated VSVGts-
GFP in patches, which did not colocalize with Sec31a in ERES 
(Figure 4C). Transfer of the dispergo-treated cells from 40 to 32°C 
confirmed  both  loss  of  VSVGts-GFP  export  from  the  ER  and 
accumulation of VSVGts-GFP as patches that did not colocalize 
with Sec31a at ERES (Figure 4D). The same results were obtained 
interpreted as cross sections of tubular structures (Figure 3F, en-
largement) and absence of stacked ER membranes. The cytosolic 
surface of these membrane profiles were smooth, and the clusters 
FIGURE 2:  Dispergo inhibits the traffic of VSVGts-GFP from the ER 
to the Golgi apparatus. BSC1 cells stably expressing GalT-tomato 
were transduced with adenovirus to express VSVGts-GFP overnight 
at 40°C. Cells were then treated with DMSO (control) or dispergo 
for 40 min at 40°C and subsequently shifted to 32°C for 20 min. 
(A) Control cells treated with DMSO only. (B–D) Cells treated with 
dispergo. Note in B the redistribution of VSVGts-GFP into patches in 
cells kept at 40°C during the dispergo treatment. (C) Under these 
experimental conditions, a significant amount of GalT-tomato 
colocalized with Giantin, validating the use of GalT-tomato as a 
Golgi marker. Endogenous Giantin was identified by 
immunostaining. (D) Colocalization of VSVGts-GFP patches with 
endogenous TRAPα, an ER marker (arrowheads) visualized by 
immunostaining in cells treated with dispergo. All images were from 
fixed BSC1 cells acquired using wide-field fluorescence microscopy. 
Scale bar, 10 μm.Volume 24  April 1, 2013  ER tubulation and exit block by dispergo  |  1023 
with cells kept at the permissive temperature for significantly lon-
ger times (unpublished data). We also determined the exchange 
dynamics between cytosolic and membrane bound COPII at the 
ERES using fluorescence recovery after photobleaching (FRAP) 
analysis and found that the exchange dynamics slightly increased 
upon dispergo treatment (Supplemental Figure S2). This result is 
in agreement with earlier observations demonstrating increased 
dynamic recruitment of COPII to ERES sites in the absence of 
cargo  recruitment  and  vesicle  budding  (Forster  et  al.,  2006). 
These  observations  suggest  that  dispergo  prevents  access  to 
ERES mainly by retaining VSVGts-GFP on ER patches.
Dispergo induces retention of Golgi proteins 
in the ER and consumption of the Golgi apparatus
Constituents of the Golgi apparatus continuously cycle between the 
Golgi and the ER (Storrie, 2005). The observed inhibition by dis-
pergo of anterograde VSVGts-GFP traffic from the ER to the Golgi 
(Figures 1 and 2) led us to test whether dispergo also prevents ER 
export of Golgi components that cycle between the ER and the 
Golgi and to ask whether this inhibition would result in loss of the 
Golgi apparatus.
We examined the effects of dispergo on the localization of Golgi 
markers with known steady-state localizations. The following pro-
teins  marked  the  cis-Golgi:  GPP130  (Linstedt  et  al.,  1997),  GFP-
ERGIC53 (Schindler et al., 1993), KDEL receptor (Tang et al., 1993), 
GM130 (Nakamura et al., 1995), and β-COP (Oprins et al., 1993); 
Giantin  marked  the  medial  Golgi  (Linstedt  et  al.,  1995),  and 
GalT-tomato marked the trans-Golgi. We also explored the effects of 
dispergo in the trans-Golgi network (TGN), as represented by Vti1a 
(Kreykenbohm et al., 2002), TGN38 (Luzio et al., 1990), Vamp4-GFP 
(Steegmaier et al., 1999), and Golgin97 (Lu et al., 2004). Dispergo 
treatment led to retention in the ER of all Golgi markers, except for 
Golgin97.  The  transmembrane  proteins  Vamp4-GFP  (Figure  5A, 
arrowheads), GFP-ERGIC53 (Figure 5B, open arrowheads), KDEL re-
ceptor (Supplemental Figure S3A), and GalT-tomato (Figure 6A) also 
accumulated in the ER patches, whereas the transmembrane pro-
teins GPP130 (Figure 5C), Giantin (Supplemental Figure S3B), Vti1a 
(Supplemental Figure S3C), and TGN38 (Supplemental Figure S3D) 
did not. The peripheral membrane protein Golgin97 (Supplemental 
Fig 3E) was released from the Golgi and appeared in the cytosol, 
whereas GM130 (Figure 5B) concentrated at the ERGIC in the vicin-
ity of ERES labeled here with Sec31a (Figure 5B, arrowheads). Using 
GM130 as an “adopted ERES marker” in dispergo-treated cells, we 
found that β-COP relocalized to this region (Supplemental Figure 
S3F). In contrast to the accumulation of VSVGts-GFP in ER patches 
(Figure  2,  B  and  D),  the  transmembrane  protein  GFP-ERGIC53 
(Figure 5B) concentrated at the ERES and in the ER patches. We also 
found that rate of redistribution from the Golgi to the ER could vary 
significantly, as exemplified by the significant relocation of GM130 
from the perinuclear Golgi region to the ERES in cells treated with 
dispergo for 20 min, whereas most of VAMP4-GFP remained in the 
perinuclear TGN (Figure 5D) in NRK cells.
To document the temporal relationship between the retention of 
Golgi components in the ER and the disappearance of the Golgi 
apparatus mediated by dispergo, we used spinning disk confocal 
microscopy to acquire time-lapse series from BSC1 cells coexpress-
ing  GFP-Sec61β  and  GalT-tomato  (Figure  6A  and  Supplemental 
Movie S4). The first detectable ER patches, which contained the ER 
marker  GFP-Sec61β  but  not  the  Golgi  marker  GalT-tomato,  ap-
peared <50 min after addition of dispergo; by this time, the drug 
had already blocked ER export of VSVGts-GFP (see Figures 2, B and 
D, and 4). After further dispergo treatment, the perinuclear fluores-
cence signal of GalT-tomato, which marks the Golgi apparatus, be-
came  barely  detectable.  Quantification  of  these  observations  is 
shown in Figure 6B. The temporal dissociation between appearance 
of ER patches (marked with GFP-Sec61β) and loss of the perinuclear 
Golgi signal (marked with GalT-tomato) suggests that loss of the 
Golgi apparatus is a secondary effect due to inhibition of ER export 
by dispergo.
The effects of dispergo are specific to the ER
In contrast to effects of dispergo on ER tubulation and the block in ER 
export, we were unable to detect perturbations in the clathrin-medi-
ated uptake of fluorescently labeled transferrin (Supplemental Figure 
S4A). The dynamics of clathrin-dependent, endocytic coated-pit for-
mation could be monitored as accumulation of the AP2 adaptor, on 
which  dispergo  had  no  effect  (Supplemental  Figure  S4B,  kymo-
graphs). Dispergo also had no effect on the distributions of early 
(Supplemental Figure S4C) and late endosomes/lysosomes (Supple-
mental Figure S4D), nor did it influence the organization of the actin 
and tubulin cytoskeleton (Supplemental Figure S4E and F). Close in-
teractions between tubular ER and mitochondria have been described 
(de Brito and Scorrano, 2010; Friedman et al., 2011); consistent with 
these observations, major alterations in the tubular ER organization 
led to mitochondrial fragmentation, as detected by MitoTracker stain-
ing in cells treated with dispergo (Supplemental Figure S4G).
ER stress does not induce formation of ER patches
To test whether cells subjected to ER stress might alter the ER mor-
phology in a way similar to that observed upon dispergo treatment, 
we incubated BSC1 cells for 24 h with tunicamycin or dithiothreitol 
(DTT) and monitored the distribution of GFP-Sec61β and calreticu-
lin. As illustrated by the results shown in the images in Supplemental 
Figure S5, generation of an acute ER stress response by treatment 
with these compounds did not generate ER patches and did not 
change in a detectable way the overall morphology of the ER.
DISCUSSION
In this study, we characterize the unique effects of the small molecule 
dispergo on the architecture of the ER and the associated strong in-
hibition of ER export. A secondary effect of dispergo is consumption 
of the Golgi apparatus, primarily due to loss of traffic in the antero-
grade but not the retrograde direction between the ER and the Golgi 
apparatus. The morphological effects of dispergo on the organiza-
tion of the ER are unrelated to the perturbations generated during 
acute ER stress response or to the ER patches observed upon condi-
tions of chemical perturbation with phenyl-2-decanoyl-amino-3-mor-
pholino-1-propanolhydrochloride and organized smooth ER gener-
ated by ectopic overexpression of ER membrane proteins (Snapp 
et al., 2003; Sprocati et al., 2006). These effects are reversible and do 
not appear to affect endocytosis, the organization of the endosomal 
and lysosomal compartments, or the actin and microtubule cytoskel-
etons. A recent study, independently conducted by one of us, un-
covered similar effects on the organization and function of the ER in 
cells treated with apogossypol (Varadarajan et al., 2012).
The relatively fast onset of the perturbations induced by dis-
pergo (17 ± 3 min; Figure 6B) suggests that it does not involve de 
novo synthesis of proteins, a conclusion we confirmed by observing 
the same effects of dispergo in cells whose protein synthesis was 
prevented by simultaneous treatment with cycloheximide (unpub-
lished data).
We do not yet know how dispergo drives the transformation of ER 
cisternae into tubules. Although in vivo generation of ER tubules re-
quires direct contact with microtubules, we can rule out an activation 1024  |  L. Lu et al.  Molecular Biology of the Cell
FIGURE 3:  Effect of dispergo on the dynamics and morphology of the ER. (A) The effects of dispergo are reversible. 
Two-dimensional time-lapse series of BSC1 cells stably expressing GFP-Sec61β treated with dispergo for 1 h, showing 
the gradual appearance of ER patches (top, solid arrowheads; see Supplemental Movie S1). After a further 2-h 
incubation with dispergo, the compound was removed (bottom). The time-lapse series shows the gradual disappearance 
of the ER patches (bottom, open arrowheads; see Supplemental Movie S2). (B, C) Two-dimensional time-lapse series 
from BSC1 cells expressing mRFP1-Sec61β (B) or GFP-Sec61β (C). The images in B highlight the disappearance of ER 
cisternae (arrowheads) and appearance of ER patches upon dispergo treatment. The images in C are from an enlarged Volume 24  April 1, 2013  ER tubulation and exit block by dispergo  |  1025 
apparatus (Voeltz et al., 2006; unpublished data). A further possibility 
is that dispergo inhibits the homotypic fusion of the tubular portion 
of the ER, leading to the accumulation of ER tubules at the expense 
of ER cisternae.
The acute ER tubulation induced by dispergo results in the ac-
cumulation of ER patches containing a large amount of condensed 
tubules. This architectural perturbation correlates with a dramatic 
interference  of  ER  export,  to  the  extent  that  the  contents  of 
the Golgi apparatus are eventually lost, presumably by retention of 
Golgi constituents in the ER as they traffic constitutively from the 
Golgi apparatus to the ER. The redistribution of Golgi constituents 
back to the ER is fundamentally different from that induced by other 
small molecules such as brefeldin A (Klausner et al., 1992; Supple-
mental Figure S5D), Exo1 (Feng et al., 2003), or Exo2 (Feng et al., 
2004), compounds known to activate a massive tubulation of Golgi 
membranes and fusion to the ER that correlates with a strong inhibi-
tion of ER exit without a detectable change in the organization of 
the ER. We also do not know why dispergo blocks ER export. One 
simple explanation is that the extensive ER tubulation induced by 
dispergo increases membrane tension to such an extent that forma-
tion of vesicular carriers is impaired. Protein movement along the 
dispergo-induced tubules does not seem to be impaired, but cer-
tain proteins do accumulate in the tubular ER patches. It is therefore 
possible that one or more key protein components required for ER 
exit are mislocalized, thereby impairing the process of carrier forma-
tion. Dispergo does not alter the distribution or peripheral density 
of ERES, although it slightly increases the exchange dynamics of 
COPII at the ERES sites. Another explanation could be that dispergo 
affects the lipid homeostasis in the ER, resulting in changes in its 
shape and function.
The effects of dispergo are reversible, since its removal allows 
recovery of the ER cisternae at the expense of the densely packed 
tubular ER patches together with reactivation of ER-to-Golgi traffic, 
leading to recovery of a functional Golgi with correct morphology. 
The properties of dispergo and the reversibility of its effects provide 
new opportunities to study the dynamics and function of the ER. 
Dispergo will be useful in identifying the molecules and interactions 
that guide these complex processes.
MATERIALS AND METHODS
Chemical synthesis of dispergo
General procedures.  All solid-phase reactions were performed in 
Poly-Prep Chromatography Columns (Bio-Rad, Hercules, CA) with 
agitation provided by a Lab-Line 3-D Rotator. After a reaction, the 
resin was washed in a standard manner: methylene chloride, then 
tetrahydrofuran,  then  2:1  tetrahydrofuran:acetonitrile,  and  then 
tetrahydrofuran; this sequence was repeated three times. Methanol 
was  added  as  needed  to  dissolve  solids.  Drying  of  resin  was 
of this interaction since extensive tubulation induced by dispergo is 
clearly observed in cells lacking microtubules after treatment with 
nocodazole. Another possibility is that dispergo activates the func-
tion of reticulons and DP1/Yop1p family proteins; these molecules 
localize to regions of high membrane curvature at the edge of the ER 
cisternae and on ER tubules. Genetic manipulations and in vitro re-
constitution studies initially suggested that these proteins drive ER 
tubulation (Hu et al., 2008), but it has since been proposed that they 
are instead essential for cisternae formation and stability (Shibata 
et al., 2010). We do not favor an activator role of dispergo on the 
function of these proteins, however, since ectopic overexpression of 
reticulon or DP1/Yop1p proteins did not generate ER patches, pre-
vent export of cargo from the ER, or affect the integrity of the Golgi 
FIGURE 4:  Dispergo blocks the recruitment of VSVGts-GFP to the 
ERES. BSC1 cells were transduced with adenovirus to express 
VSVGts-GFP overnight at 40°C. Cells were treated with either DMSO 
(control) or dispergo for 40 min (A, C). Subsequently, the temperature 
was shifted to 32°C for 10 min (40°C→32°C; B, D) before fixation and 
immunofluorescence detection of endogenous Sec31a. Images were 
acquired using wide-field fluorescence microscopy. The enlarged 
boxed regions in the merge images are shown in the bottom left of 
the corresponding composite images. Arrowheads highlight the 
colocalization of VSVGts-GFP with Sec31a in control. Scale bar, 10 μm.
region of A, bottom, and show the reversal of these effects upon removal of dispergo. Scale bars, 10 μm. (D) Rapid 
exchange of GFP-Sec61β within ER patches and with adjacent ER. The images are from a FRAP experiment conducted 
on an ER patch (green box) in a BSC1 cell stably expressing GFP-Sec61β pretreated with dispergo for 3 h (see 
Supplemental Movie S3). The ER patch within the unbleached region (red box) was used as a FRAP control. Scale bar, 
10 μm. (E) Quantification of the mean fluorescence intensity within the boxed regions of the FRAP experiment. 
(F) Example of electron microscopy images obtained from BSC1 cells treated with dispergo for 3 h in the absence of 
ectopic expression of proteins. Left, ER patches highlighted with solid arrowheads. N, nucleus. Scale bar, 2 μm. Right, 
enlarged highlights of the abundance of relatively circular small membrane profiles contained within the ER patches; 
membrane profiles ∼100 nm in width extending away from the ER patches are highlighted with open arrowheads. Scale 
bar, 500 nm. (G) Dispergo induces ER tubules and patches in the absence of microtubules. BSC1 cells stably expressing 
GFP-Sec61β were first treated with nocodazole for 2 h (left), followed by nocodazole and dispergo for an additional 2 h. 
Scale bar, 10 μm. All fluorescence images were acquired live using spinning disk confocal microscopy.1026  |  L. Lu et al.  Molecular Biology of the Cell
performed under house vacuum. Cleavage of resin was performed 
by swelling the resin in tetrahydrofuran (1 ml per 10 mg of resin), 
followed by addition of HF-pyridine (200 μl per 10 mg of resin), 
agitation for 1 h, treatment with methoxytrimethylsilane (1 ml per 
10 mg of resin), agitation for 1 h, and filtration. Flash chromatography 
was performed as described previously (Still et al., 1978) or by using 
an  HPFC  Biotage  system  (Biotage,  Uppsala,  Sweden)  with  pre-
packed FLASH silica gel columns.
Preparation  of  dispergo.  Cyclopentanethiol (428 μl, 4.0 mmol), 
2,6-lutidine (465 μl, 4.0 mmol), and n-butyllithium (2.5 M in hexane, 
192 μl, 4.0 mmol) were added to a mixture of resin loaded with 
carpanone-like core (Goess et al., 2006), and the resulting mixture 
was agitated for 24 h. The resin was then subjected to the standard 
wash  and  dry  procedure  outlined  in  General  procedures.  To 
the  resulting  resin  was  added  a  premixed  solution  of  O-t-
butylhydroxylamine (804 mg, 6.4 mmol), pyridine (776 μl, 9.6 mmol), 
and a 1:4 mixture of methanol:methylene chloride (20 ml), and the 
resulting mixture was agitated for 20 h. The resin was then subjected 
to  the  standard  wash  and  dry  procedure.  To  the  resulting  resin 
(50 mg, 0.04 mmol) was added tetrahydrofuran (5 ml), followed by 
HF•pyridine (2 ml), and the resulting mixture was agitated for 2 h. 
Methoxytrimethylsilane (10 ml) was then added, and the resulting 
mixture was agitated for 45 min. The mixture was then filtered and 
washed with methylene chloride, and the combined filtrates were 
concentrated and the remaining volatiles evaporated under high 
vacuum. Column chromatography (0:100–4:96 methanol:methylene 
chloride) afforded 10 mg (54%, three steps) of dispergo. Dispergo 
was isolated as a 4:1 (E/Z) mixture of geometrical isomers. 1H nuclear 
magnetic resonance (NMR; 400 MHz, CDCl3): δ 6.91 (s, 1H), 6.58–
6.72 (m, 3H), 6.26–6.36 (m, 1H), 6.13 (bs, 1H), 5.98–6.10 (m, 1H), 
5.56–5.64 (m, 1H), 5.36–5.42 (m, 1H), 5.22–5.34 (m, 1H), 4.96–5.04 
(m, 1H), 4.86–4.96 (m, 1H), 4.40–4.54 (m, 3H), 3.88–4.12 (m, 3H), 
3.76 (bs, 1H), 3.58–3.76 (m, 4H), 3.47 (t, J = 6.0 Hz, 3H), 3.20–3.36 
(m, 3H), 2.90–3.04 (m, 2H), 2.65 (dd, J = 14.2, 2.2 Hz, 1H), 2.38 (bs, 
1H), 1.05–2.05 (m, 20H), 0.80–1.02 (m, 2H), 0.66–0.80 (m, 2H); 13C 
NMR  (100  MHz,  CDCl3):  δ  152.81,  152.76,  152.6,  150.3,  145.6, 
145.5, 138.1, 134.4, 133.7, 131.6, 127.34, 127.28, 126.9, 122.1, 
117.9, 117.6, 116.4, 114.9, 114.8, 113.5, 100.6, 100.2, 78.4, 69.9, 
63.1, 62.4, 62.3, 61.7, 61.6, 45.6, 44.3, 42.6, 41.4, 39.8, 39.6, 37.0, 
36.7, 35.12, 35.07, 35.0, 34.7, 34.6, 34.4, 34.1, 33.8, 33.5, 33.4, 
33.11, 33.06, 32.9, 32.8, 28.0, 27.7, 26.9, 25.1, 24.9, 24.60, 24.57, 
24.3, 24.2; IR (neat, cm-1): 3367, 2929, 1624, 1492, 1422, 1196, 
1132, 1076; LRMS (ES+): 668 (M+H+); HRMS (ES+): calculated for 
C39H57NO6S, 667.3907; found, 668.3995.
Reagents and antibodies
Nocodazole was from Sigma-Aldrich (St. Louis, MO). Rhodamine–
phalloidin and transferrin–Alexa Fluor 488 were from Invitrogen 
(Carlsbad, CA). Mouse monoclonal antibody against GM130 was 
from  Becton  Dickinson  (Franklin  Lakes,  NJ).  Rabbit  polyclonal 
antibodies  against  calreticulin  and  Giantin  were  from  Abcam 
(Cambridge, MA). Rabbit polyclonal antibody against β-COP was 
from  EMD  Chemicals  (San  Diego,  CA).  Hybridoma  clone  8g5, 
FIGURE 5:  Disappearance of the Golgi apparatus and retention of its 
components in the ER induced by dispergo. (A–C) Cells were treated 
for 3 h with DMSO (control) or dispergo before immunofluorescence 
labeling to follow the distributions of several ER (TRAPα, GFP-Sec61β, 
and Sec31a) and Golgi apparatus (VAMP4-GFP, GM130, ERGIC53-
GFP, and GPP130) markers. (A) NRK cells stably expressing Vamp4-
GFP immunostained with an anti-TRAPα antibody. Arrowheads 
highlight the colocalization of Vamp4-GFP and TRAPα in ER patches. 
(B) BSC1 cells transiently expressing GFP-ERGIC53 immunostained 
with antibodies specific for GM130 and Sec31a. The arrowheads in 
the enlarged boxed region highlight colocalization of GFP-ERGIC53 
and GM130 at the ERES marked by Sec31a. Empty arrowheads 
indicate the ERGIC53-positive ER patches induced by dispergo. 
(C) BSC1 cells stably expressing GFP-Sec61β labeled with anti-
GPP130 antibody. The images highlight lack of enrichment of GPP130 
in ER patches. (D) Golgi markers had different kinetics of relocation 
upon dispergo treatment. NRK cells stably expressing Vamp4-GFP 
without or with dispergo treatment for 20 min were processed for 
immunofluorescence labeling of GM130. This example highlights that 
the redistribution of Golgi markers to the ER can occur at different 
rates (in this case GM130 was faster than Vamp4-GFP). All images 
were acquired by a wide-field microscope. Scale bars, 10 μm.Volume 24  April 1, 2013  ER tubulation and exit block by dispergo  |  1027 
CD63 and Lamp1 were obtained from the Developmental Studies 
Hybridoma Bank (University of Iowa, Iowa City, IA). Rabbit poly-
clonal  antibodies  against  Sec31a  and  Golgin97  were  from 
W.  Hong  (Institute  of  Molecular  and  Cell  Biology,  Singapore). 
Rabbit polyclonal antibody against TRAPα was from T. Rapaport 
(Harvard  Medical  School,  Boston,  MA).  Rabbit  polyclonal 
and  mouse  monoclonal  antibodies  against  GPP130  were  from 
A.  Linstedt  (Carnegie  Mellon  University,  Pittsburgh,  PA).  Goat 
anti-mouse and rabbit secondary antibodies conjugated with ei-
ther Alexa Fluor 488 or 594 were purchased from Invitrogen.
DNA plasmids
To clone GalT-tomato, an insert containing the coding sequence of 
amino acids 1–81 of β-galactosyltransferase (GalT) was released by 
digesting  pEYFP-Golgi  plasmid  (Takara  Bio,  Shiga,  Japan)  using 
NheI/BamHI and subsequently ligated into NheI/BamHI-digested 
ptdTomato-N1 vector (Takara Bio) to make plasmid GalT-tomato. 
Plasmids Sec61β in pAcGFP1-C1 (Takara Bio), HA-DP1 in pcDNA3, 
and Sec61β-mRFP1 were from T. Rapaport. Plasmid ERGIC53-GFP 
was from H.-P. Hauri (University of Basel, Basel. Switzerland). Plas-
mid expressing GFP–α-tubulin was from Takara Bio.
Cell culture, transfection, and stable cell lines
BSC1  and  HeLa  cells  were  obtained  from  the  American  Tissue 
Culture Collection. Cells were cultured at 37ºC in DMEM supple-
mented with 10% fetal bovine serum. The transfection experiments 
were  performed  using  FuGENE  6  transfection  reagent  (Roche, 
Basel, Switzerland) according to the manual.
To generate cell lines stably expressing GalT-tomato or GFP-
Sec61β,  BSC1  cells  were  transfected  with  either  GalT-tomato  or 
GFP-Sec61β. Pooled stable cells were selected in medium contain-
ing 0.5 mg/ml G418 (Invitrogen) and subsequently replated at very 
low density to obtain single colonies of cells. Colonies were screened 
by fluorescence microscopy, isolated, and subsequently expanded. 
NRK (normal rat kidney) cells stably expressing Vamp4-GFP (Tran 
et al., 2007) were from W. Hong. All stable cell lines were main-
tained in medium supplemented with 0.1 mg/ml G418.
Dispergo, nocodazole, brefeldin A, tunicamycin, 
and DTT treatments
Dispergo  was  dissolved  in  dimethyl  sulfoxide  (DMSO)  to  make  a 
10 mM stock solution and stored at −20ºC. The stock solution was 
directly diluted in culture medium to a final working concentration of 
20 μM. DMSO, 0.2%, was used as control in parallel with dispergo 
treatments. Nocodazole was dissolved in DMSO at a concentration 
of 33 mM and stored at −20°C. The final working concentration of 
nocodazole was 16.5 μM dissolved in culture medium. Brefeldin A 
and tunicamycin were also dissolved in DMSO as 10 mM stock solu-
tions, which were then directly diluted in culture medium to a final 
working concentration of 10 μM. DTT was dissolved in water to make a 
100 mM stock, and the final working concentration of 100 μM was 
achieved by directly diluting the stock in culture medium.
Immunostaining
Cells grown on round glass coverslips were fixed in 4% paraformal-
dehyde in phosphate-buffered saline (PBS) for 20 min at room tem-
perature. Paraformaldehyde was subsequently blocked by incuba-
tion with 100 mM NH4Cl. After extensive washes with PBS, cells 
were simultaneously permeabilized and stained with the required 
antibodies diluted in PBS containing 0.1% saponin, 5% fetal bovine 
serum, and 2% bovine serum albumin. Coverslips were mounted in 
Mowiol and sealed with nail polish.
which secretes mouse monoclonal antibody against VSVG extra-
cellular domain, was obtained from the American Type Culture 
Collection (Rockville, MD). Mouse monoclonal antibodies against 
FIGURE 6:  Relocalization of the Golgi marker GalT-tomato to the ER 
induced by dispergo. (A) BSC1 cell transiently expressing GalT-tomato 
and GFP-Sec61β were treated with dispergo and imaged by spinning 
disk confocal microscopy (see Supplemental Movie S4). Arrowheads 
highlight colocalization of GalT-tomato and GFP-Sec61β at ER patches 
marked by GFP-Sec61β. Scale bar, 10 μm. (B) Time dependence for 
the loss of GalT-tomato from the perinuclear region corresponding to 
the Golgi apparatus induced by dispergo in BSC1 cells stably 
expressing GalT-tomato. The fluorescence intensity of GalT-tomato at 
the perinuclear region determined before dispergo addition was used 
to normalize the data. Plot shows mean values and SD for each time 
point (n = 13 cells). Golgi t1/2 represents the mean time ± SD that it 
took for the signal of GalT-tomato to be reduced by 50%. “ER patches 
onset” marks the time at which the appearance of ER patches labeled 
with GFP-Sec61β was first detected (n = 10 cells).1028  |  L. Lu et al.  Molecular Biology of the Cell
VSVGts-GFP trafficking assays
Recombinant  adenovirus  expressing  a  temperature-sensitive  mu-
tant vesicular stomatitis virus glycoprotein G (VSVGts) fused to GFP 
(VSVGts-GFP) was generated by subcloning the PCR fragment span-
ning cytomegalovirus promoter-VSVGts-GFP-poly(A) into the NotI 
site of the pShuttle vector, followed by viral packaging as described 
previously (He et al., 1998). BSC1 cells plated on glass coverslips 
were infected with the adenovirus overnight in a 40°C CO2 incuba-
tor. Cells were subsequently incubated with media containing dis-
pergo at 40°C for 40 or 60 min and transferred to 32°C to release 
VSVGts-GFP for various lengths of time as indicated before immuno-
fluorescence microscopy.
Fluorescence microscopy
Wide-field epifluorescence microscopy of fixed samples was per-
formed on an upright microscope (Axioskop; Carl Zeiss, Thornwood, 
NY),  equipped  with  a  63×/numerical  aperture  1.4  Plan-Apochro-
matic oil immersion objective lens, a motorized focus unit (Applied 
Scientific Instrumentation, Eugene, OR), a spherical aberration cor-
rection device (Infinity Photo-Optical, Boulder, CO), and a cooled 
charge-coupled device (CCD) camera (Roper CoolSnap HQ; Photo-
metrics, Tucson, AZ). Spinning disk confocal fluorescence images 
were  acquired  with  an  inverted  microscope,  Axiovert  200M 
(Carl Zeiss), equipped with a spinning disk confocal head (CSU10 or 
22; Yokogawa Electric, Tokyo, Japan), a spherical aberration correc-
tion  device  (Infinity  Photo-Optical),  an  electron-multiplying  CCD 
camera (Cascade 512B; Photometrics), and 473- and 561-nm laser 
light sources (Crystal Lasers, Reno, NV). The two-dimensional time-
lapse imaging described in Figure 6B was conducted in an inverted 
wide-field  microscope,  Axiovert  200M,  equipped  with  a  cooled 
CCD camera (Roper CoolSnap HQ). Microscopes were controlled 
under SlideBook software (Intelligent Imaging Innovations, Denver, 
CO). Live-cell imaging was performed as previously described (Lu 
et al., 2009, 2011). To quantify the perinuclear intensity of GalT-
tomato described in Figure 6B, time-lapse images were subjected 
to segmentation, and the total intensity of the masked perinuclear 
region of each cell was summed at each time point. Series of inten-
sity values as a function of elapsed time were normalized and plot-
ted using OriginPro 8 (Origin Lab, Northampton, MA).
Electron microscopy
Samples were chemically fixed using 2.5% glutaraldehyde in 0.1 M 
cacodylate buffer for 1 h, postfixed with 1% osmium tetroxide, fol-
lowed by 1% uranyl acetate and then dehydrated with serial dilu-
tions of ethanol. Samples were embedded in resin, cut into thin 
sections, stained with uranyl acetate followed by lead acetate, and 
viewed on a 1200EX transmission electron microscope at 80 kV 
(JEOL, Peabody, MA).
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